The syndrome of familial adenomatous polyposis has a wide spectrum of clinical manifestations including adenomatous polyps of the colon and small bowel, adenocarcinoma of ampulla of Vater, tumors of the central nervous system, bone lesions, and various soft tissue tumors. Familial adenomatous polyposis of the colon is an autosomal dominant disease in which virtually all affected individuals develop colorectal cancer before the age of 40.
The gene responsible for familial adenomatous polyposis of the colon (APC gene) is mutated in the germ line of patients. The genetic diagnosis of familial adenomatous polyposis of the colon was initially done using linkage analysis. The low-penetrance susceptibility APC I1307K allele confers a relative risk of 1.5-2.0 for colorectal cancer. The APC allele with lysine (K) at codon 1307, commonly referred to in the literature as I1307K, results from the T-A transition at nt 3920 in APC, which causes an extended mononucleotide tract (A8). This mononucleotide repeat impairs replication fidelity, forming a mutational hotspot.